The stock market indices started the week off in a very strange session, the Nasdaq 100 working its way higher, while the S&P 500 got hammered at the opening, and barely hung on all morning. Midday the Nasdaq 100 extended its move, making new, all-time highs today at 5034.00, while the S&P 500 tried to rally, but rolled over and continued steadily lower. At the end of the day, the Nasdaq 100 pulled back ten points, while a much deeper retrace on the session lows of the S&P 500 and Dow finished at the lows for the day.

Net on the day, the Dow was down 76.42 at 19,887.38, the exact tick low of the day. The S&P 500 was down 8.08 at 2268.90. The Nasdaq 100 was up 17.82 at 5024.90.

Advance-declines were 500 issues lower on the New York Stock Exchange than that of the Nasdaq. Up/down volume was 2 to 1 negative on New York, total volume of 3.1 billion shares traded. The Nasdaq traded 1.7 billion shares and had a 3 to 2 positive volume ratio.

TheTechTrader.com board was mixed. Priceline.com (PCLN) was up 9.07 to 1529.64, Alphabet Inc. (GOOG) up 50 cents to 806.65, Apple Inc. (AAPL) up 1.09 to 119.00, Amazon.com, Inc. (AMZN) 87 cents to 796.86, but Netflix, Inc. (NFLX) dropped 12 cents to 130.96.

Baidu, Inc. (BIDU) popped 78 cents to 177.16, Facebook, Inc. (FB) gained 1.49 to 124.90, and First Solar, Inc. (FSLR) advanced 25 cents to 33.57.

Tesla Motors, Inc. (TSLA) jumped 2.27 to 231.28.

Other stocks to the upside included Exact Sciences Corporation (EXAS) up 2.88 to 17.98, Exelixis, Inc. (EXEL) 2.26 to 17.58, Clovis Oncology Inc (CLVS) 4.83 to 50.86, CoLucid Pharmaceuticals, Inc. (CLCD) 1.50 to 33.45, Aclaris Therapeutics, Inc. (ACRS) 1.05 to 30.01.

The Direxion Daily S&P Biotech Bull 3X ETF (LABU) bounced 3.64 to 41.73, about 50 cents off its high.

On the downside, Emergent BioSolutions Inc. (EBS) lost 2.62 to 32.04, Argan, Inc. (AGX) gave back 3.25 to 70.05, and United States Steel Corp. (X) dropped 1.79 to 33.61.

Checking TheTechTrader.com percent-gain leaderboard, CTI BioPharma Corp. (CTIC) popped 98 cents, or 20%, to 5.78, on 2.1 million shares traded.

EnteroMedics Inc. (ETRM) jumped 8.51, or 93%, to 17.70, on 35.6 million shares traded, trading under 2.00 just four days ago. Asure Software, Inc. (ASUR) bounced 1.56, or 17%, to 10.93. 3D Systems Corporation (DDD), on takeover rumors, ran 2.27, or 16%, to 16.73, on 13.6 million shares traded.

Stepping back and reviewing the hourly chart patterns, the indices were up all day on the Nasdaq 100, and pretty much down all day on the S&P 500.

Quite the divergence. We’ll see if that resulted in any further downside damage in the next few days.

Good Trading!

Harry

For more of Harry Boxer, sign up for a FREE 7-Day Trial to his Real-Time Technical Trading Diary.

(c) 2016 AdviceTrade, Inc. All rights reserved. Distributed only by written permission of AdviceTrade and The Technical Trader at info@advicetrade.com . In using any portion of Harry Boxer's content, you agree to the terms and conditions governing the use of the service as described in our disclaimer at http://www.thetechtrader.com

Mr. Boxer's commentaries and index analysis represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Trades mentioned on the site are hypothetical, not actual, positions.

Harry Boxer Archive

Only logged in users are allowed to post comments. Register/ Log in

The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2024 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any other financial instrument at any time. We recommend that independent professional advice is obtained before you make any investment or trading decisions. By using this site you agree to this sites Terms of Use. From time to time we promote or endorse certain products / services that we believe are worthy of your time and attention. In return for that endorsement and only in the cases where you purchase directly though us may we be compensated by the producers of those products.